GARKX
Price
$8.40
Change
-$0.00 (-0.00%)
Updated
Apr 21 closing price
Net Assets
10.48M
MGLIX
Price
$15.77
Change
+$0.13 (+0.83%)
Updated
Apr 24 closing price
Net Assets
2.19B
Ad is loading...

GARKX vs MGLIX

Header iconGARKX vs MGLIX Comparison
Open Charts GARKX vs MGLIXBanner chart's image
Goldman Sachs Global Rl Estt Secs C
Price$8.40
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets10.48M
MFS Global Real Estate I
Price$15.77
Change+$0.13 (+0.83%)
VolumeN/A
Net Assets2.19B
GARKX vs MGLIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GARKX vs. MGLIX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GARKX is a Buy and MGLIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.19B vs. GARKX (10.5M). MGLIX pays higher dividends than GARKX: MGLIX (2.61) vs GARKX (1.61). GARKX was incepted earlier than MGLIX: GARKX (10 years) vs MGLIX (16 years). GARKX (2.44) is less costly to investors than MGLIX (0.95). MGLIX (48.00) and GARKX (47.00) have comparable annual turnover. MGLIX has a lower initial minimum investment than GARKX: MGLIX (0) vs GARKX (1000). MGLIX annual gain was more profitable for investors over the last year : 2.35 vs. GARKX (-3.47). MGLIX return over 5 years is better than : 21.58 vs. GARKX (7.47).
GARKXMGLIXGARKX / MGLIX
Total Expense Ratio2.050.94218%
Annual Report Gross Expense Ratio2.440.95257%
Fund Existence10 years16 years-
Gain YTD-9.648-2.494387%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets10.5M2.19B0%
Annual Yield % from dividends1.612.6162%
Returns for 1 year-3.472.35-148%
Returns for 3 years-24.89-21.16118%
Returns for 5 years7.4721.5835%
Returns for 10 yearsN/A19.21-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOCQX43.02N/A
N/A
Tocqueville
JFNAX63.90N/A
N/A
Janus Henderson Global Life Sciences A
GMVRX14.37N/A
N/A
Goldman Sachs Small/Mid Cap Value R
NSFOX10.22N/A
N/A
Natixis Target Retirement 2065 N
GTDIX33.14N/A
N/A
Invesco EQV Emerging Markets All Cap R5